HighTower Advisors LLC decreased its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 6.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,634 shares of the technology company’s stock after selling 1,097 shares during the quarter. HighTower Advisors LLC’s holdings in Veeva Systems were worth $3,261,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC boosted its stake in Veeva Systems by 30.4% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 12,363 shares of the technology company’s stock valued at $2,263,000 after buying an additional 2,884 shares in the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Veeva Systems by 44.9% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 29,782 shares of the technology company’s stock valued at $5,450,000 after buying an additional 9,232 shares in the last quarter. Triad Wealth Partners LLC purchased a new stake in shares of Veeva Systems in the second quarter valued at about $115,000. Blue Trust Inc. increased its holdings in Veeva Systems by 3,460.0% during the second quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock worth $33,000 after buying an additional 173 shares during the last quarter. Finally, Rovin Capital UT ADV increased its stake in shares of Veeva Systems by 29.0% in the second quarter. Rovin Capital UT ADV now owns 3,669 shares of the technology company’s stock worth $671,000 after purchasing an additional 825 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.
Veeva Systems Stock Down 0.6 %
Veeva Systems stock opened at $232.48 on Friday. The stock has a 50-day moving average price of $220.31 and a 200 day moving average price of $203.63. The company has a market capitalization of $37.65 billion, a price-to-earnings ratio of 57.82, a price-to-earnings-growth ratio of 2.43 and a beta of 0.82. Veeva Systems Inc. has a 52 week low of $170.25 and a 52 week high of $258.93.
Insider Activity at Veeva Systems
Wall Street Analyst Weigh In
Several research analysts have commented on VEEV shares. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday, November 9th. Stifel Nicolaus boosted their target price on Veeva Systems from $240.00 to $272.00 and gave the stock a “buy” rating in a research report on Friday, December 6th. Bank of America upped their price target on shares of Veeva Systems from $280.00 to $290.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Citigroup increased their target price on shares of Veeva Systems from $281.00 to $307.00 and gave the stock a “buy” rating in a report on Monday. Finally, Canaccord Genuity Group upped their price target on Veeva Systems from $210.00 to $270.00 and gave the stock a “hold” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and eighteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus target price of $255.35.
View Our Latest Report on VEEV
Veeva Systems Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- Russell 2000 Index, How Investors Use it For Profitable Trading
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Most active stocks: Dollar volume vs share volume
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Retail Stocks Investing, Explained
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.